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INTRODUCTION
The global burden of disease from alcohol exceeds that of
tobacco and is on a par with the burden attributable to unsafe
sex practices world-wide (World Health Organization, 1999).
Accurate self report strategies, biological state markers,
combinations of alternative biomarkers, and combinations of
biomarkers and self reports capable of monitoring alcohol
consumption with a high sensitivity and specificity over the
entire time spectrum are needed.
Especially during the last decade, three non-oxidative direct
ethanol metabolites have attracted attention. Promising markers
of this type include fatty acid ethyl esters (FAEE) (Wada et al.,
1971; Doyle et al., 1994, 1996; Dan and Laposata, 1997;
Diczfalusy et al., 1999, 2001), ethyl glucuronide (EtG) (Schmitt
et al., 1995; Alt et al., 2000; Seidl et al., 2001; Wurst et al.
1999a,b, 2000, 2002, 2003), and phosphatidyl ethanol (PEth)
(Alling et al., 1983, 1984; Hansson et al., 1997; Gunnarsson 
et al., 1998; Varga et al., 1998, 2000). Each of these remains
positive in serum and urine for a characteristic time spectrum
after cessation of alcohol intake: FAEE in serum up to 24 h, EtG
in urine up to 5 days, PEth in whole blood more than 2 weeks.
Recent studies have supported the use of phosphatidyl
ethanol (PEth) in blood as a marker of alcohol misuse.
Chronic alcohol-dependent patients admitted for detoxi-
fication had mean PEth levels of 13.2 mol/l on the first day,
and levels remained detectable up to 14 days after admission
(Hansson et al., 1997). Using liquid chromatography electrospray
mass spectrometric detection (HPLC–ELSD), PEth has been
detected in extracts of blood from alcoholics (Gunnarsson et
al., 1998). These patients had PEth levels of 5–13 mol/l,
which remained detectable up to 3 weeks after the beginning
of an alcohol-free period. A third study on chronic alcoholics
showed mean PEth levels of 2.5 and 5.1 mol/l in two
different groups respectively (Varga et al., 2000). A study on
healthy volunteers revealed that a single dose of ethanol
(32–47 g) does not produce measurable amounts of PEth
(Varga et al., 1998). However, out of twelve volunteers who
consumed between 624 and 2134 g of ethanol during a 3 week
period, eight persons produced levels of PEth of 1.0–2.1
mol/l. A threshold of total ethanol intake yielding detectable
PEth seems to be around 1000 g, with a mean daily intake of
about 50 g. Thus far, analysis of PEth has been performed
using whole blood, however, a recent study on blood from
chronic alcoholics showed that almost all PEth was found in
the erythrocyte fraction (Varga et al., 2000).
Fatty acid esters of ethanol (FAEE) have been implicated as
possible mediators for at least some of the toxic effects
associated with alcohol consumption, as short term markers of
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Abstract — Aims: In a variety of clinical and forensic situations long term use of alcohol must be monitored. In this project we
explore the utility of fatty acid ethyl esters (FAEE) in this regard. Additionally, we propose a cut-off value of FAEE to distinguish
teetotallers/moderate/social drinkers from alcoholics or individuals drinking at harmful levels. Patients and methods: FAEE levels
from 18 alcohol-dependent patients in detoxification were contrasted with those of 10 social drinkers and 10 teetotallers. FAEE in hair
were determined, using headspace solid phase microextraction and gas chromatography mass spectrometry. CFAEE, as sum of the
concentrations of four esters, was compared to a major FAEE, ethyl palmitate. PEth was measured in heparinized whole blood with a
high pressure liquid chromatography (HPLC) method. Drinking validation criteria include self reports, phosphatidyl ethanol (PEth) in
whole blood as well as the traditional markers of heavy drinking, gamma glutamyl transpeptidase (GGT), mean corpuscular volume
(MCV) and carbohydrate deficient transferrin (CDT). Results: Receiver-operating characteristic (ROC) curve analysis for CFAEE,
indicated a sensitivity of 100% and a specificity of 90% for a cut-off of 0.29 ng/mg. By using a cut-off of 0.4 ng/mg, CFAEE identified
94.4% correctly. CFAEE and ethyl palmitate were significantly associated (r = 0.945; P < 0.001) as were CFAEE and PEth (r = 0.527; 
P = 0.025). No significant correlation was found between CFAEE and total grams of ethanol consumed last month, blood-alcohol
concentration at admission to the hospital, CDT, MCV, or GGT. Among the serum and blood markers, %CDT identified 47.1%, MCV
38.8% and GGT 72.2% of patients with chronic intake of higher amounts of ethanol correctly, whereas PEth achieved 100% accuracy.
Conclusions: The data suggest that CFAEE is a potentially valuable marker of chronic intake of high quantities of ethanol. Furthermore,
the results indicate that a reasonable and provisional FAEE cut-off to distinguish between social/moderate and heavy
drinking/alcoholism in hair is 0.4 ng/mg.
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ethanol intake in serum and as long term markers in hair.
Direct toxic effects of FAEE have not been demonstrated
(Laposata and Lange, 1986; Doyle et al., 1996; Dan and
Laposata, 1997; Soderberg et al., 1999), although these esters
have been shown to uncouple mitochondrial oxidative
phosphorylation in rabbit heart (Lange and Sobel, 1983),
inhibit protein synthesis and cell proliferation in human
hepatoblastoma cells (Szczypiorkowski et al., 1995) and
render pancreatic lysosomes more fragile (Haber et al., 1993).
Two enzymatic activities catalyse the formation of FAEE:
acyl-coenzyme A:ethanol O-acyltransferase (AEAT) and fatty
acid ethyl ester (FAEE) synthases. FAEE synthases have been
purified from several sources, including rabbit myocardium,
human brain and rat adipose tissue, and two of these FAEE
synthases were found to be identical to rat liver carboxy-
lesterase (Tsujita and Okuda, 1992; Bora et al., 1996).
Furthermore, a variety of other enzymes (e.g. pancreatic
lipase, lipoprotein lipase and gluthathione transferases) reveal
FAEE synthase activity (Tsujita and Okuda, 1992; Bora et al.,
1989; Riley et al., 1990; Tsujita and Okuda, 1994; Chang
et al., 1997). At present there is no evidence for the existence
of a specific FAEE synthase and the formation of FAEE
from free fatty acids seems to result from the interplay of
a host of enzymes and other functions. The enzyme
responsible for most of the AEAT activity in rat liver is
localized at the lumenal side of the endoplasmic reticulum
(Polokoff and Bell, 1978), but has not yet been identified or
purified. Characterization of AEAT and FAEE synthase
activities using isolated rat liver microsomes and human tissue
homogenates suggests that AEAT is quantitatively the
more important of these two activities (Diczfalusy et al., 1999,
2001).
FAEE have also been suggested as markers of ethanol
intake. In serum and erythrocytes, FAEE can be detected up to
24 h after drinking. They are not stable in blood samples due
to continued enzyme activity, but are incorporated into hair
and can be analysed in this medium even after several months
(Pragst et al., 2001). In these investigations, the sum of the
concentrations (CFAEE) of the four esters: ethyl myristate, ethyl
palmitate, ethyl oleate and ethyl stearate, was used as an
alcohol intake marker. The incorporation was found to occur
mainly from sebum into the completed hair, which results in
an increase of CFAEE by accumulation from proximal to distal
hair sections (Auwärter et al., 2001). Beside the effects of
inter-individual differences in the sebum production, variables
such as the kind and frequency of hair care and hair cosmetics
can influence the efficiency of deposition (Hartwig et al.,
2003a). The differences in CFAEE between hair samples from
different sites of the same individual can be explained in the
same way (Hartwig et al., 2003b).
Based on earlier investigation of hair samples from fatalities
with known excessive alcohol consumption, patients in
withdrawal treatment, social drinkers and teetotallers, a cut-off
value for CFAEE of 1.0 ng/mg has been suggested to establish
heavy alcohol use (Auwärter et al., 2001; Hartwig et al., 2003b).
Our aim in this project is to further evaluate FAEE in hair as
an indicator of chronic intake of high amounts of ethanol and
to consider the effect of using a lower cut-off to identify heavy
drinking/alcohol dependence by comparing FAEE in hair with




A total of 18 detoxification inpatients (14 male; 4 female)
meeting ICD 10 criteria of alcohol-dependence were included.
They had the following characteristics (median, SD and range
is given): age 44 (SD 9.5; 24–55) years, blood alcohol
concentration at admission to hospital 1.82 mg/dl (SD 0.73;
0.05–2.92), BMI 21.7 (SD 5.04; 16.6–37.6), grams of ethanol
consumed last month 4440 (SD 2039; 960–7600), age of onset
of disorder 22 (SD 10.3; 15–46) years, duration of disorder
16 (SD 7.17; 2–27) years, number of previous detoxifications
4 (SD 8.1; 0–30), number of cigarettes smoked per day 20 (SD
12.6; 0–50).
Data on alcohol use were obtained by using the timeline
follow back procedure. The alcohol intake of the last month
was reported to be representative for the last half year. Blood
samples were taken at day 1 and hair samples at day 7 of
hospitalization.
For comparison, previously published data from 10 social
drinkers and 10 teetotallers (Pragst et al., 2001) were
employed. The comparison sample included seven male and
13 female subjects with a mean age of 32.9 (SD 17.9) years.
The self reported ethanol consumption in grams per day was
52 (mean, SD12.3, mean 60) for the social drinkers and zero
for the teetotallers. For the teetotallers, CFAEE was 0.0 mean(SD 0.0, median 0.0) and for the social drinkers 0.21 mean
(SD 0.1, mean 0.7) [ng/mg]. In the Kruskal Wallis test the
three groups (teetotallers, social drinkers, alcoholics) were
significantly different (P < 0.0001).
The study was reviewed by the Bavarian Chamber of
Physicians Ethical Committee and all patients gave written
informed consent.
Methods
FAEE in hair. The analytical determination of the four FAEE
was performed by external decontamination of the hair with
n-heptane, liquid extraction with a dimethylsulphoxide/
n-heptane mixture, separation and evaporation of the n-heptane
layer, solid phase micro-extraction of the residue and gas
chromatography-mass spectrometry using deuterated standards
of all four esters. The experimental details, limits of detection,
assay reproducibility and standard deviations have been
described elsewhere (Pragst et al., 2001; Hartwig et al., 2003b).
Phosphatidyl ethanol in whole blood. PEth was measured in
heparinized whole blood as described elsewhere by high pressure
liquid chromatography (HPLC) combined with an evaporative
light-scattering detector (ELSD) method (Varga et al., 2000).
%CDT in serum. CDT estimation was performed on
duplicate serum samples using the %CDT turbidimetric
immunoassay kit (Bio-Rad Laboratories, Philadelphia, PA,
USA) according to the manufacturer’s instructions. This
method is based on micro anion-exchange chromatography
followed by turbidimetric measurement. Isoelectric focusing to
exclude rare genetic D-variants was undertaken as previously
described followed by semi-quantitative evaluation by means
of a scanner (Bean and James, 1994; Kuchheuser et al., 1995).
Cut-off values. The cut-off of 1.0 ng/mg for CFAEE was
compared with 0.4 ng/mg, as suggested by data from several
studies and from ROC curve analysis. In addition, the
conventional cut-off (0.4 ng/mg) for ethyl palmitate, which
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usually accounts for about 40% of CFAEE, was compared with
a cut-off of 0.16 ng/mg.
Statistical analysis
For statistical analysis (descriptive statistics, Spearman rank
correlation, Kruskal Wallis test) SPSS 11 was used (SPSS
Inc., Chicago, IL).
RESULTS
The following biomarker median values were found for the
alcohol detoxification patients (Table 1): CFAEE 1.09 ng/mg, ethyl
palmitate 0.46 ng/mg, GGT 50.5 U/L, MCV 95.3 fl, and PEth
3.7 nmol/l. Detailed information regarding hair length, ethyl
myristate, ethyl palmitate, ethyl oleate, ethyl stearate and CFAEE
is given in Table 2.
Receiver-operating characteristic (ROC) curve analysis
(Fig. 1) indicated a sensitivity of 100% and a sensitivity of 90%
for a cut-off of 0.29 ng/mg and a sensitivity of 94.4% and
specificity of 90% for a cut-off of 0.46 ng/mg. Use of a cut-off
value of 0.4 ng/mg on CFAEE identified 94.4% and a cut-off of 0.7
ng/mg resulted in 88.9% correct identifications. In contrast, only
55.6% were found with the cut-off of 1.0 ng/mg. The area under
the curve (AUC) to distinguish between teetotallers/
moderate/social drinkers and harmful drinking/alcohol
dependence by comparing FAEE in hair is 0.983.
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Table 1. Descriptive statistics of parameters determined in alcohol detoxification patients
Expression MCV[fl] GGT [U/L] CFAEE [ng/mg] Ethyl palmitate [ng/mg] PEth [nmol/L]
Median 95.3 50.5 1.09 0.46 3.7
SD 4.86 98.8 0.67 0.289 2.35
Range 89.2–107.4 12–316 0.39–3.19 0.09–1.26 0.63–8.68
Reference values: MCV < 98 fL; GGT: < 20 U/L for females; < 28 U/L for males; CFAEE 1.0 ng/mg; ethyl palmitate 0.4 ng/mg; phosphatidylethanol(PEth) < limit of detection (LOD). MCV (mean corpuscular volume); GGT (-glutamyl transferase); CFAEE (concentration of fatty acid ethyl esters);
PEth (phosphatidylethanol).
Table 2. Hair length, concentrations of the four esters ethyl myristate, ethyl palmitate, ethyl oleate, ethyl stearate and the sum of their concentrations
(CFAEE) in alcohol detoxification patients
Hair Length Determined Ethyl myristate Ethyl palmitate Ethyl oleate Ethyl stearate CFAEE
Case (cm) [ng/mg] [ng/mg] [ng/mg] [ng/mg] [ng/mg]
1 0–6 0.20 0.89 0.71 0.26 2.06
2 0–6 0.47 1.26 1.26 0.20 3.19
3 0–6 0.11 0.68 0.76 0.16 1.71
4 0–5.5 0.08 0.49 0.97 0.15 1.69
5 0–4 0.07 0.46 0.56 0.13 1.22
6 0–1.5 0.02 0.27 0.35 0.09 0.73
7 0–4 0.01 0.33 0.41 0.09 0.84
8 0–6 0.01 0.22 0.47 0.20 0.90
9 0–6 0.02 0.09 0.18 0.10 0.39
10 0–6 0.09 0.36 0.51 0.11 1.07
11 0–4.5 0.08 0.66 0.60 0.11 1.45
12 0–6 0.05 0.53 1.12 0.21 1.91
13 0–2.5 0.04 0.53 0.38 0.16 1.11
14 0–3.5 0.04 0.34 0.48 0.18 1.04
15 0–5 0.12 0.70 0.72 0.21 1.75
16 0–5 0.03 0.10 0.33 0.07 0.53
17 0–3 0.01 0.26 0.45 0.12 0.84
18 0–4.5 0.03 0.47 0.44 0.12 1.06
Fig. 1. ROC curve analysis for CFAEE to distinguish between
teetotallers/social drinkers and heavy drinkers/alcoholics. Area under the 








Table 3. Comparison of self reported ethanol consumption and true positive results for different biomarkers in alcohol detoxification patients
Subject EtOH  CFAEE Cut-off: CFAEE Cut-off: Ethyl Palmitate Ethyl Palmitate PEth (ref. 
no. Sex Last month [g] 1 [ng/mg] 0.4 [ng/mg] Cut-off: 0.4 [ng/mg] Cut-off: 0.16 [ng/mg] CDT MCV GGT value: < LOD)
1 M 7280 Pos Pos Pos Pos — — Pos Pos
2 F 5600 Pos Pos Pos Pos — — — Pos
3 F 7600 Pos Pos Pos Pos Pos Pos Pos Pos
4 M 5600 Pos Pos Pos Pos – — Pos Pos
5 M 3200 Pos Pos Pos Pos Pos — — Pos
6 M 3200 — Pos — Pos — — — Pos
7 M 7360 — Pos — Pos — — Pos Pos
8 F 6400 — Pos — Pos — Pos Pos Pos
9 M 4400 — — — — — Pos — Pos
10 F 3800 Pos Pos — Pos — — Pos Pos
11 M 4480 Pos Pos Pos Pos Pos Pos Pos Pos
12 M 5600 Pos Pos Pos Pos Pos — Pos Pos
13 M 1120 Pos Pos Pos Pos md Pos Pos Pos
14 M 3360 Pos Pos — Pos — Pos Pos Pos
15 M 4000 Pos Pos Pos Pos Pos — Pos Pos
16 M 5280 — Pos — — Pos Pos Pos Pos
17 M 1680 — Pos — Pos Pos — Pos Pos
18 M 960 Pos Pos Pos Pos Pos — Pos
12/18 17/18 10/18 16/18 8/17 7/18 13/18 18/18
55.6% 94.4% 55.6% 88.9% 47.1% 38.8% 72.2% 100%
Pos, exceeding the cut-off; –, below the cut-off; md, missing data; reference values: %CDT,  < 6%, MCV,  < 98 fl; GGT, < 20 U/L for females;  < 28 U/L for males; CFAEE, 1.0 ng/mg; ethyl palmitate
0.4 ng/mg; phosphatidyl ethanol (PEth)  limit of detection (LOD).
Ethyl palmitate performed with 55.6% for the higher
(0.4 ng/mg) and 88.9% with the lower cut-off (0.16 ng/mg).
Table 3 gives a synopsis of the results for the blood/serum
markers as well as CFAEE and ethyl palmitate with different
cut-offs. Among the serum/blood markers, %CDT identified
47.1%, MCV 38.8% and GGT 72.2% of the alcoholics
correctly, whereas PEth reached 100%.
A significant Spearman rank correlation was found between
CFAEE and ethyl palmitate (r = 0.945; P < 0.001) and CFAEE and
PEth (r = 0.527; P = 0.025).
Correlations were not significant between CFAEE and total
grams of ethanol consumed last month, blood-alcohol
concentration at admission to hospital, hair length, CDT,
MCV, GGT, age, number of previous detoxifications, number
of previous admissions to hospital, age of first hospitalization,
age of onset of disorder, years of duration of disorder and total
amount of clomethiazole required for the treatment of
withdrawal symptoms.
DISCUSSION
Numerous tests and devices have been developed and suggested
to uncover alcohol consumption (Gilg and Soyka, 1997;
Laposata, 1999). Biological tests can, in addition to self reports,
provide clinicians, forensic toxicologists, judges, counsellors
and programme evaluators etc. with complementary
information. Other roles of biomarkers in alcoholism treatment
have been recently discussed by Allen and Litten (2001). These
include serving as outcome variables in treatment efficacy
studies, early identification of relapse in patients in abstinence-
oriented interventions, and serving as a basis for feedback to
enhance patient motivation for change. Granted their ability to
monitor heavy drinking use over long periods of time, FAEE
hair levels may play an important and unique role in both
clinical practice and research. The present study is, to our
knowledge, the first to compare CFAEE in hair with self reports
and biomarkers including GGT, MCV, and PEth (Varga et al.,
1998, 2000; Wurst et al., 2003) as measures of ethanol intake
exceeding 50 g/day for the previous period of at least 2 weeks.
ROC curve analysis indicated a sensitivity for CFAEE of
100% and a specificity of 90% at a cut-off of 0.29 and
sensitivity of 94.4% and a specificity of 90%, respectively, for
a cut-off of 0.46 ng/mg in distinguishing teetotallers/social
drinkers and heavy drinkers/alcohol dependency (AUC =
0.983). In contrast, only 55.6% of alcohol-dependent patients
with previous chronic ethanol intake were identified with the
cut-off of 1.0 ng/mg.
As in previous investigations, concentrations of FAEE were
also found in hair of teetotallers (Auwärter et al., 2001), but
CFAEE was never above 0.4 ng/mg. The origin of FAEE in these
cases is not yet clear. Generally social drinkers have CFAEE
<0.4 ng/mg, but there were also some cases of social drinkers
with CFAAE up to 0.8 ng/mg. However, the possibility can not
be dismissed that some of those individuals, although
currently being non-dependent social drinkers, drank at levels
comparable to those of alcohol-dependent patients.
Furthermore, it is seen from the cases described in this study,
as well as from the patients on withdrawal treatment described
previously (Auwärter et al., 2001), that a cut-off of 1.0 ng/mg
leads to excessive numbers of negative results. In contrast to
the post-mortem cases with clearly higher CFAEE, the patients
investigated here during inpatient detoxification washed their
hair regularly, thus decreasing FAEE incorporation from
sebum.
Interesting as well and meriting further research attention is
the near-comparable performance of ethyl palmitate in
isolation to CFAEE in this study. Nevertheless, CFAEE is the more
usual criterion for ethanol consumption and additionally,
possible external contamination can more likely be excluded
by the ratio of the four esters.
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